TIFFANY LASERNA: Open Payments
NPI 1376172692 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 7 payments from 7 companies in 2025. Trend: 2023 $658 · 2024 $216 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| SERVIER PHARMACEUTICALS LLC | 1 | $130 |
| Apellis Pharmaceuticals, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $122 |
| JAZZ PHARMACEUTICALS INC. | 1 | $120 |
| E.R. Squibb & Sons, L.L.C. | 1 | $117 |
| EMD Serono, Inc. | 1 | $106 |
Products named: Empaveli, IMDELLTRA (AMG757), CERDELGA, ZIIHERA, REBLOZYL.
Industry payments across AL — which companies pay providers there.
